Immunophenotypic characteristics of multipotent mesenchymal stromal cells that affect the efficacy of their use in the prevention of acute graft vs host disease

doi:10.4252/wjsc.v12.i11.1377

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5443)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-5) series.

Item

Count

PDF

279

WORD

223

HTML

2452

Figures (1-6)

344

Tables (1-5)

238

Sum=3536

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

617

Download

1290

Sum=1907

Nov 26, 2020 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Stem Cells. Nov 26, 2020; 12(11): 1377-1395
Published online Nov 26, 2020. doi: 10.4252/wjsc.v12.i11.1377

Full Size Figure Download Figure

Figure 1 Experimental design. MSCs: Multipotent mesenchymal stromal cells; PBMCs: Peripheral blood mononuclear cells; PHA: Phytohemagglutinin; IL: Interleukin; IFN: Interferon; TNF: Tumour necrosis factor.

Citation: Petinati N, Kapranov N, Davydova Y, Bigildeev A, Pshenichnikova O, Karpenko D, Drize N, Kuzmina L, Parovichnikova E, Savchenko V. Immunophenotypic characteristics of multipotent mesenchymal stromal cells that affect the efficacy of their use in the prevention of acute graft vs host disease. World J Stem Cells 2020; 12(11): 1377-1395
URL: https://www.wjgnet.com/1948-0210/full/v12/i11/1377.htm
DOI: https://dx.doi.org/10.4252/wjsc.v12.i11.1377